Publications by authors named "Gregory Cheng"

Claim this Profile
F
Fermented rice bran extract delays skin aging by increasing the synthesis of collagen and elastin.
Xin Yan, Meiqing Yang, Xuyi Cai, Yiwei Shen, Ruihan Jiang, Gregory Cheng, Yuen Yee Cheng

Front Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.
George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Ann-Lii Cheng, Gregory Cheng

Hepatol Int· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled study.
Fang-Jiao Song, Hong-Ling Liu, Ying Sun, Tian-Jiao Xu, Dong-Ze Li, Gregory Cheng

ILIVER· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Gregory Cheng, Ann Lii Cheng

Hepatol Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Yoshioka et al.
Dong Ji, Enqiang Qin, Dawei Zhang, Gregory Cheng, George Lau

Clin Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Gregory Cheng, Ann Lii Cheng

Hepatol Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving WHO target of HCV control in Hong Kong: challenges and strategies.
Yudong Wang, Gregory Cheng, George Lau

Glob Health Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study.
Dong Ji, Guo-Feng Chen, Xiao-Xia Niu, Mingjie Zhang, Cheng Wang, Gregory Cheng

Metabol Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues".
Dong Ji, Gregory Cheng, George Lau

J Hepatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.
Dong Ji, Mingjie Zhang, Enqiang Qin, Lunqing Zhang, Jing Xu, Gregory Cheng

Metabolism· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Grifoni et al.
Dong Ji, Enqiang Qin, Dawei Zhang, Gregory Cheng, George Lau

Clin Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening.
Fangyuan Shao, Xueying Lyu, Kai Miao, Lisi Xie, Haitao Wang, Gregory Cheng

Adv Sci (Weinh)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
Dong Ji, Dawei Zhang, Jing Xu, Zhu Chen, Tieniu Yang, Gregory Cheng

Clin Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'.
Dong Ji, Jing Xu, Enqiang Qin, Dawei Zhang, Gregory Cheng

J Hepatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of COVID-19 on patients with compensated chronic liver diseases.
Dong Ji, Dawei Zhang, Tieniu Yang, Jinsong Mu, Peng Zhao, Gregory Cheng

Hepatol Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.
Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng

J Hepatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.
Hongling Liu, Xi He, Yudong Wang, Shuangnan Zhou, Dali Zhang, Gregory Cheng

Hepatol Int· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia.
Lunqing Zhang, Mingjie Zhang, Xin Du, Yunfeng Cheng, Gregory Cheng

Br J Haematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalable Generation of Mesenchymal Stem Cells from Human Embryonic Stem Cells in 3D.
Li Yan, Bin Jiang, Enqin Li, Xiaoyan Wang, Qinjie Ling, Gregory Cheng

Int J Biol Sci· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-Wide Genetic Risk Prediction of Complex Diseases: A Pilot Feasibility Study in Macau Population for Precision Public Healthcare Planning.
Nancy B Y Tsui, Gregory Cheng, Teresa Chung, Christopher W K Lam, Anita Yee

Sci Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
Uwe Platzbecker, Raymond S M Wong, Amit Verma, Camille Abboud, Sergio Araujo, Gregory Cheng

Lancet Haematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries" [Bioorg. Med. Chem. Lett. 22 (2012) 3213-3218].
Pik-Ling Lam, Kenneth Ka-Ho Lee, Raymond Siu-Ming Wong, Gregory Yin Ming Cheng, Shuk Yan Cheng

Bioorg Med Chem Lett· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombopoietin Receptor Agonists for the treatment of ITP.
Gregory Cheng

Rinsho Ketsueki· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel green gelatin-agar microencapsulation system with P. urinaria as an improved anti-A. niger model.
Pik-Ling Lam, Stanton Hon-Lung Kok, Yiu-Wah Ho, Raymond Siu-Ming Wong, Gregory Yin-Ming Cheng, Chor-Hing Cheng

Carbohydr Polym· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.
Gregory Cheng

Ther Adv Hematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis